Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Horst

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Physiology. Cell Physiology|January 9, 2023
Evolving roles of activins and inhibins in ovarian cancer pathophysiologyElizabeth T Evans, Ben Horst, Rebecca C Arend, et al.
Cytokine & Growth Factor Reviews|January 3, 2018
Dually modified transmembrane proteoglycans in development and diseaseLaura M Jenkins, Ben Horst, Carly L Lancaster, et al.
Plos One|April 5, 2021
A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumorsEduardo Listik, Ben Horst, Alex Seok Choi, et al.
Oncogene|May 22, 2018
Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancerAnne Serrao, Laura M Jenkins, Alexander A Chumanevich, et al.
Molecular Genetics and Metabolism|January 23, 2026
Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrierRenuka Raman, Ben Horst, Zahra Shahrokh, et al.
Cancer Research|March 15, 2018
Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and MetastasisPriyanka Singh, Laura M Jenkins, Ben Horst, et al.
Communications Biology|June 2, 2022
Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancersBen Horst, Shrikant Pradhan, Roohi Chaudhary, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Physiology. Cell Physiology|January 9, 2023
Evolving roles of activins and inhibins in ovarian cancer pathophysiologyElizabeth T Evans, Ben Horst, Rebecca C Arend, et al.
Cytokine & Growth Factor Reviews|January 3, 2018
Dually modified transmembrane proteoglycans in development and diseaseLaura M Jenkins, Ben Horst, Carly L Lancaster, et al.
Plos One|April 5, 2021
A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumorsEduardo Listik, Ben Horst, Alex Seok Choi, et al.
Oncogene|May 22, 2018
Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancerAnne Serrao, Laura M Jenkins, Alexander A Chumanevich, et al.
Molecular Genetics and Metabolism|January 23, 2026
Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrierRenuka Raman, Ben Horst, Zahra Shahrokh, et al.
Cancer Research|March 15, 2018
Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and MetastasisPriyanka Singh, Laura M Jenkins, Ben Horst, et al.
Communications Biology|June 2, 2022
Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancersBen Horst, Shrikant Pradhan, Roohi Chaudhary, et al.
Pageof 1